Mode
Text Size
Log in / Sign up

NF-κB signaling integrates mechanical stress and immunity in osteoarthritis joint degeneration

NF-κB signaling integrates mechanical stress and immunity in osteoarthritis joint degeneration
Photo by julien Tromeur / Unsplash
Key Takeaway
Consider NF-κB signaling as a potential therapeutic target in osteoarthritis, but recognize the evidence is preclinical and mechanistic.

This is a narrative review that examines the role of NF-κB signaling in osteoarthritis (OA), focusing on how it integrates mechanical stress, innate immunity, and metabolic cues to drive joint degeneration. The authors synthesize evidence showing that NF-κB acts as a central hub linking these diverse pathogenic inputs, leading to cartilage breakdown and inflammation. They highlight that mechanical overload, damage-associated molecular patterns, and metabolic factors converge on this pathway, amplifying catabolic and inflammatory responses in chondrocytes and synovial cells.

The review discusses how innate immune receptors, such as Toll-like receptors, activate NF-κB in response to cartilage matrix fragments, perpetuating a cycle of degeneration. Metabolic cues, including adipokines and advanced glycation end-products, also modulate NF-κB activity, linking obesity and aging to OA progression. The authors propose that understanding these interactions could lead to mechanism-based patient stratification and rational combination therapies.

Limitations of the review include its narrative nature, which may introduce selection bias, and the lack of quantitative synthesis. The authors do not report specific effect sizes or clinical outcomes. They acknowledge that the evidence is largely preclinical and that translating these insights into effective therapies remains challenging.

Practice relevance: The review suggests new directions for precision interventions aimed at restoring joint homeostasis, emphasizing the importance of targeting NF-κB signaling in specific OA subtypes. However, clinicians should note that these are early mechanistic insights, and no specific therapeutic recommendations can be made at this time.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Osteoarthritis (OA) is a complex and multifactorial joint disease that was traditionally regarded as a consequence of mechanical wear and tear, but is now increasingly recognized as a disorder driven by chronic low-grade inflammation and dysregulated stress responses. Nuclear factor-κB (NF-κB) has emerged as a pivotal regulator in OA; however, its role extends well beyond that of a linear inflammatory pathway. In this review, we synthesize recent evidence supporting NF-κB as an important integrative signaling node through which mechanical stress, innate immune activation, and metabolic cues converge to influence joint degeneration. We discuss how mechanotransduction mediated by ion channels, mitochondrial dysfunction-associated DNA sensing, and danger-associated molecular patterns converge on NF-κB activation, thereby establishing feed-forward inflammatory circuits. Downstream, NF-κB-associated signaling is closely involved in extracellular matrix degradation, chondrocyte fate decisions—including senescence, apoptosis, and ferroptosis—synovial inflammation and fibrosis, immune microenvironment remodeling, and subchondral bone alterations. Importantly, the biological consequences of NF-κB signaling are highly context dependent and are shaped by the source, intensity, and duration of upstream stimuli, as well as by the metabolic and aging status of joint cells. Finally, we summarize emerging therapeutic strategies targeting NF-κB-associated networks at multiple hierarchical levels and highlight the importance of mechanism-based patient stratification and rational combination therapies. By positioning NF-κB as a hub of signaling integration, this review provides a unifying framework for understanding OA pathogenesis and suggests new directions for precision interventions aimed at restoring joint homeostasis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.